Galapagos N.V.
Galapagos N.V. (GLPG) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GLPG · as of Sep 30, 2025
Ownership Breakdown
98
Institutional Holders
▲ 2 vs Q2
$1.09B
Total Inst. Value
▲ $200.51M vs Q2
65.90M
Shares Outstanding
freeFloat 67.56%
31.40M
13F Shares Held
▼ 296,509 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GLPG largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
GILEAD SCIENCES, INC. pharmaceutical preparations | 16.71M | 25.38% | 25.38% | $578.75B | Nov 13, 2025 | — held |
TANG CAPITAL MANAGEMENT LLC pharmaceutical preparations | 4.15M | 6.31% | 6.31% | $143.80B | Nov 14, 2025 | ▲ 161.1K |
MADISON AVENUE PARTNERS, LP pharmaceutical preparations | 2.20M | 3.34% | 3.34% | $76.06B | Nov 14, 2025 | ▲ 318.8K |
ECOR1 CAPITAL, LLC pharmaceutical preparations | 1.67M | 2.53% | 2.53% | $57.75B | Nov 14, 2025 | ▲ 630.2K |
AMERIPRISE FINANCIAL INC pharmaceutical preparations | 1.42M | 2.15% | 2.15% | $49.08B | Nov 14, 2025 | ▲ 1.36M |
PROSIGHT MANAGEMENT, LP pharmaceutical preparations | 1.15M | 1.75% | 1.75% | $39.84B | Nov 14, 2025 | ▼ 623.6K |
SEGALL BRYANT & HAMILL, LLC pharmaceutical preparations | 487.2K | 74.00% | 74.00% | $16.88B | Nov 12, 2025 | ▼ 13.9K |
DME CAPITAL MANAGEMENT, LP pharmaceutical preparations | 482.7K | 73.32% | 73.32% | $16.72B | Nov 14, 2025 | — held |
POINT72 ASSET MANAGEMENT, L.P. pharmaceutical preparations | 443.9K | 67.42% | 67.42% | $15.38B | Nov 14, 2025 | ▲ 102.4K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 356.2K | 54.10% | 54.10% | $12.34B | Nov 13, 2025 | ▼ 108.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
19
Increased
+2.81M shares6
New Positions
first time holders19
Decreased
−3.11M shares0
Sold Out
fully exitedNet shares change (top 50)
294.9K
+2.81M / −3.11M
Net new holders
+6
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GLPG insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Galapagos N.V. (GLPG) is primarily owned by institutional investors, who hold approximately 47.6% of total shares outstanding. Company insiders own approximately 32.44%, while retail and public investors account for the remaining 19.91%.
The largest institutional shareholder of Galapagos N.V. is GILEAD SCIENCES, INC., holding approximately 16.71 million shares — equal to 25.38% of outstanding shares — as of September 30, 2025.
A total of 98 institutional investors currently hold GLPG stock, with a combined institutional value of approximately $1.09 billion as of the most recent 13F filing period.
Frequently asked questions
GLPG ownershipGalapagos N.V. (GLPG) is primarily owned by institutional investors, who hold approximately 47.6% of shares. The largest shareholder is GILEAD SCIENCES, INC. with a 25.38% stake. Company insiders hold 32.44%. Data sourced from SEC Form 13F as of September 30, 2025.